Nanomerics is pleased to announce a major milestone in toxicology testing of its Molecular Envelope Technology has been completed.
Latest News and Events
Nanomerics’ scientists have demonstrated that encapsulating chemotherapy drugs within Nanomerics’ MET nanoparticles diverts the drug from the bone marrow, while enabling higher levels of drug to access the brain.
Nanomerics is pleased to announce the strengthening of its Scientific Advisory Board with the appointment of Professor Martin Koltzenburg.
Professor Koltzenburg’s appointment will support the clinical development of Nanomerics' lead product NM0127, a novel pain therapeutic based on an endogenous peptide.